TenNor Therapeutics Suzhou Ltd. Class H(HK:6872)
HK$68.60-1.00 (-1.44%)
HK:6872
TenNor Therapeutics Suzhou Ltd. Class H financials statements
HK$68.60
At close:-1.00 (-1.44%)
Want to see HK:6872 full AI Analyst Report?
TenNor Therapeutics Suzhou Ltd. Class H (6872) Income Statement
TenNor Therapeutics Suzhou Ltd. Class H Income Statement
Last quarter (Q4 2025), TenNor Therapeutics Suzhou Ltd. Class H's total revenue was ¥0.00. In Q4, TenNor Therapeutics Suzhou Ltd. Class H's net income was ¥-37.78M. See TenNor Therapeutics Suzhou Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| ¥ 0.00 | ¥ 0.00 | ¥ 0.00 | |
| ¥ 0.00 | ¥ 0.00 | ¥ 0.00 | |
| ¥ 118.67M | ¥ 78.00M | ¥ 122.48M | |
| Depreciation and Amortization | ¥ 1.58M | ¥ 2.70M | ¥ 2.88M |
| ¥ -150.18M | ¥ -141.35M | ¥ -186.61M | |
| ¥ -118.67M | ¥ -78.00M | ¥ -122.48M | |
| ¥ -34.57M | ¥ -67.93M | ¥ -69.36M | |
| ¥ -153.24M | ¥ -145.93M | ¥ -191.84M | |
| ¥ -153.24M | ¥ -145.93M | ¥ -191.84M | |
| Per Share Metrics | |||
| Basic EPS | ¥ -2.96 | ¥ -2.82 | ¥ -3.71 |
| Diluted EPS | ¥ -2.96 | ¥ -2.82 | ¥ -3.71 |
| Weighted Average Shares Outstanding | 51.75M | 51.75M | 51.75M |
| Weighted Average Shares Outstanding (Diluted) | 51.75M | 51.75M | 51.75M |
Currency in CNY

